Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Clinical Microbiology & Infectious Diseases
Metadata
Title
Azithromycin versus placebo in acute infectious rhinitis with clinical symptoms but without radiological signs of maxillary sinusitis
Authors
R. Haye
E. Lingaas
H. O. HØivik
T. Ødegård
Publication date
01-05-1998
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/1998
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/BF01709452

Other articles of this Issue 5/1998

European Journal of Clinical Microbiology & Infectious Diseases 5/1998 Go to the issue

Note

Infective endocarditis due toStenotrophomonas (Xanthomonas) maltophilia

Note

Predisposing conditions and pathogens in bacteremia in hospitalized children

Editorial

Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapy

Note

Two cases of chronic arthritis of the forearm due toMycobacterium tuberculosis

Brief Reports

Non-simultaneousBrucella peritonitis and meningitis in a patient with a ventriculoperitoneal shunt

Article

An inexpensive and reliable method for routine identification of staphylococcal species

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits